Elena Sabini

1.4k total citations · 1 hit paper
30 papers, 990 citations indexed

About

Elena Sabini is a scholar working on Pathology and Forensic Medicine, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Elena Sabini has authored 30 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 17 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Oncology. Recurrent topics in Elena Sabini's work include Ophthalmology and Eye Disorders (16 papers), Pituitary Gland Disorders and Treatments (9 papers) and Thyroid Disorders and Treatments (7 papers). Elena Sabini is often cited by papers focused on Ophthalmology and Eye Disorders (16 papers), Pituitary Gland Disorders and Treatments (9 papers) and Thyroid Disorders and Treatments (7 papers). Elena Sabini collaborates with scholars based in Italy, United States and United Kingdom. Elena Sabini's co-authors include Paolo Vitti, Eleonora Molinaro, Rossella Elisei, Agnese Biagini, Salvatore Mazzeo, Laura Agate, Stefano Sellari‐Franceschini, Michele Marinò, Fulvio Basolo and Claudio Marcocci and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Endocrinology.

In The Last Decade

Elena Sabini

29 papers receiving 975 citations

Hit Papers

Anaplastic thyroid carcinoma: from clinicopathology to ge... 2017 2026 2020 2023 2017 100 200 300

Peers

Elena Sabini
Paul V. Newcomb United Kingdom
Pia Alhopuro Finland
H Stobbe Germany
Heather Hardin United States
Paul V. Newcomb United Kingdom
Elena Sabini
Citations per year, relative to Elena Sabini Elena Sabini (= 1×) peers Paul V. Newcomb

Countries citing papers authored by Elena Sabini

Since Specialization
Citations

This map shows the geographic impact of Elena Sabini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Sabini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Sabini more than expected).

Fields of papers citing papers by Elena Sabini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Sabini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Sabini. The network helps show where Elena Sabini may publish in the future.

Co-authorship network of co-authors of Elena Sabini

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Sabini. A scholar is included among the top collaborators of Elena Sabini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Sabini. Elena Sabini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabini, Elena, et al.. (2025). Sirolimus for the treatment of Graves’ orbitopathy. Thyroid Research. 18(1). 55–55. 1 indexed citations
2.
Dottore, Giovanna Rotondo, Elena Sabini, Chiara Posarelli, et al.. (2025). Markers of fibrosis in orbital tissues from patients graves’ orbitopathy: a retrospective cohort study. Journal of Endocrinological Investigation.
3.
Sabini, Elena, Francesca Menconi, Chiara Posarelli, et al.. (2025). Serum levels of rapamycin predict the response of Graves’ orbitopathy to sirolimus. Journal of Endocrinological Investigation. 48(7). 1677–1682. 2 indexed citations
4.
Lanzolla, Giulia, Christophe Merceron, Mohd Parvez Khan, et al.. (2024). Osteoblastic erythropoietin is not required for bone mass accrual. JBMR Plus. 8(6). ziae052–ziae052. 2 indexed citations
5.
Lanzolla, Giulia, Elena Sabini, Mohd Parvez Khan, et al.. (2024). Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiency. Proceedings of the National Academy of Sciences. 121(49). e2416004121–e2416004121. 1 indexed citations
6.
Khan, Mohd Parvez, Elena Sabini, Giulia Lanzolla, et al.. (2024). HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation. JCI Insight. 9(18). 1 indexed citations
7.
Sabini, Elena, et al.. (2023). Oxidative phosphorylation in bone cells. Bone Reports. 18. 101688–101688. 19 indexed citations
8.
McLeod, Donald S.A., Sheryl A. Bedno, David S. Cooper, et al.. (2022). Pre-existing Thyroid Autoimmunity and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study of US Active-Duty Personnel. Journal of Clinical Oncology. 40(23). 2578–2587. 19 indexed citations
9.
Ippolito, Silvia, Giulia Di Dalmazi, Fabiana Pani, Elena Sabini, & Patrizio Caturegli. (2021). Distinct Cytokine Signatures in Thyroiditis Induced by PD-1 or CTLA-4 Blockade: Insights from a New Mouse Model. Thyroid. 31(12). 1839–1849. 13 indexed citations
10.
Lanzolla, Giulia, Elena Sabini, Marenza Leo, et al.. (2021). Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial. The Lancet Diabetes & Endocrinology. 9(11). 733–742. 60 indexed citations
11.
Lanzolla, Giulia, Debora Ricci, Elena Sabini, et al.. (2020). Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study. Journal of Endocrinological Investigation. 43(12). 1759–1768. 21 indexed citations
12.
Hage, Camilla, Elena Sabini, Jill A. Fahrner, et al.. (2019). Acromegaly in the setting of Tatton-Brown-Rahman Syndrome. Pituitary. 23(2). 167–170. 5 indexed citations
13.
Lanzolla, Giulia, Elena Sabini, Maria Antonietta Profilo, et al.. (2018). Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study. Journal of Endocrinological Investigation. 41(12). 1417–1423. 52 indexed citations
14.
Sabini, Elena, Ilaria Ionni, Angela Tindara Sframeli, et al.. (2017). Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients. Journal of Endocrinological Investigation. 41(3). 357–361. 5 indexed citations
15.
Sabini, Elena, Ilaria Ionni, Roberto Rocchi, et al.. (2017). Occurrence of Graves’ Orbitopathy and Graves’ Hyperthyroidism after a Trauma to the Eye. European Thyroid Journal. 7(1). 51–54. 3 indexed citations
16.
Molinaro, Eleonora, Cristina Romei, Agnese Biagini, et al.. (2017). Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nature Reviews Endocrinology. 13(11). 644–660. 347 indexed citations breakdown →
17.
Menconi, Francesca, Marenza Leo, Elena Sabini, et al.. (2016). Natural history of graves’ orbitopathy after treatment. Endocrine. 57(2). 226–233. 14 indexed citations
18.
Sabini, Elena, Eleonora Sisti, B. Coco, et al.. (2016). Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves’ orbitopathy. Journal of Endocrinological Investigation. 39(11). 1323–1327. 8 indexed citations
19.
Viola, David, Laura Valerio, Eleonora Molinaro, et al.. (2016). Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocrine Related Cancer. 23(4). R185–R205. 146 indexed citations
20.
Lorusso, Loredana, Letizia Pieruzzi, Agnese Biagini, et al.. (2016). Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer. OncoTargets and Therapy. Volume 9. 6467–6477. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026